Investment Analysts’ updated eps estimates for Wednesday, August 9th:

AAC Holdings (NYSE:AAC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AAC Holdings, Inc. is a provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction. It provides detoxification, residential treatment, partial hospitalization, and intensive outpatient care services. AAC Holdings, Inc. is headquartered in Brentwood, Tennessee. “

Alliance Holdings GP, L.P. (NASDAQ:AHGP) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $30.00 target price on the stock. According to Zacks, “Alliance Holdings GP, L.P., through its subsidiaries, produces and markets coal primarily to utilities and industrial users in the United States. It produces a range of steam coal with varying sulfur and heat contents. Alliance Holdings GP, L.P. is a limited partnership formed to own and control Alliance Resource Management GP, LLC, the managing general partner of Alliance Resource Partners, L.P., a publicly traded limited partnership engaged in the production and marketing of coal to major U.S. utilities and industrial users. . In addition, the company leases land and operates a coal loading terminal. . Further, it engages in trading of coal, as well as offers services, including ash and scrubber sludge removal, coal yard maintenance, and arranging alternate transportation services. The company is based in Tulsa, Oklahoma. “

Ashford Hospitality Prime (NYSE:AHP) was downgraded by analysts at Zacks Investment Research from a buy rating to a sell rating. According to Zacks, “Ashford Hospitality Prime, Inc. is a real estate investment trust. It is focused on investing in high RevPAR full-service and urban select-service hotels and resorts located predominantly in domestic and international gateway markets. Ashford Hospitality Prime, Inc. is based in Dallas, Texas. “

Amber Road (NYSE:AMBR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $9.00 price target on the stock. According to Zacks, “Amber Road, Inc. operates as a provider of on-demand Global Trade Management solutions. It offers import and export, global logistics, and trade agreement management solutions worldwide. The Company’s solutions include Enterprise-Class Software, Trade Content, Supply Chain Network, Flexible Technology and SaaS Delivery. It offers its solution to enterprises in various industries, including chemical/pharmaceutical, high technology/electronics, industrial/manufacturing, logistics, oil and gas, and retail/apparel through a software-as-a-service model. Amber Road, Inc. is headquartered in East Rutherford, New Jersey. “

ARI Network Services (NASDAQ:ARIS) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “ARI Network Services, Inc. is a provider of business-to-business Internet e-commerce solutions for manufacturers with shared distribution and service networks. The company currently serves segments of the manufactured equipment market, including Outdoor Power, Recreation Vehicle, Floor Maintenance, Marine, and Construction. The company’s communications systems provide an electronic pathway for parts orders, warranty claims, and other transactions between manufacturers and their networks of sales and service points. “

Aspen Aerogels (NYSE:ASPN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $5.25 price target on the stock. According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “

America First Multifamily Investors, L.P. (NASDAQ:ATAX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $6.75 target price on the stock. According to Zacks, “America First Tax Exempt Investors, L.P. is a consistently performing fund with a portfolio of federally tax-exempt mortgage revenue bonds; interest on these bonds is excludable from gross income for federal tax purposes. As a result, most of the income earned by the Partnership is exempt from federal income taxes. “

Bravo Brio Restaurant Group (NASDAQ:BBRG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $3.25 target price on the stock. According to Zacks, “Bravo Brio Restaurant Group, Inc. is an owner and operator of two distinct Italian restaurant brands, BRAVO! Cucina Italiana and BRIO Tuscan Grille. BRAVO! Cucina Italiana is a full-service, upscale Italian restaurant offering a menu of freshly prepared classic Italian food. BRAVO offers variety of pasta dishes, steaks, chicken, seafood and pizzas. It also offers seasonal specials, an extensive wine list, carry-out and catering. BRIO Tuscan Grille is an upscale Italian chophouse restaurant serving authentic northern Italian food in a Tuscan Villa atmosphere. The cuisine at BRIO includes steaks, chops, fresh seafood and made-to-order pastas. BRIO also offers creative seasonal specials, an extensive wine list, and carry-out and banquet facilities at select locations. It also operates one full-service upscale American-French bistro restaurant in Columbus, Ohio under the brand Bon Vie. Bravo Brio Restaurant Group is based in Columbus, Ohio. “

BioCryst Pharmaceuticals (NASDAQ:BCRX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $5.00 price target on the stock. According to Zacks, “BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries. “

Bright Horizons Family Solutions (NYSE:BFAM) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.

Brighthouse Financial (NASDAQ:BHFWV) had its sell rating reiterated by analysts at Citigroup Inc.. They currently have a $50.00 price target on the stock.

Bioverativ (NASDAQ:BIVV) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a sell rating. According to Zacks, “Bioverativ Inc. is a biotechnology company. It focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders. Bioverativ Inc. is based in Waltham, United States. “

bluebird bio (NASDAQ:BLUE) had its hold rating reiterated by analysts at Morgan Stanley.

Barnes & Noble Education (NYSE:BNED) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Barnes & Noble Education, Inc. is engaged in creating and operating campus bookstores for academic institutions under multi-year management service agreements. The Company’s products and services include Textbook and Course Material Sales, Textbook and Course Material Rentals, General Merchandise, Trade, Digital Education Platform, e-commerce Platform, FacultyEnlight, Campus Connect Technologies platform and Flexible Course Fee Solution. It operates primarily in the United States. Barnes & Noble Education, Inc. is based in Basking Ridge, United States. “

Benefitfocus (NASDAQ:BNFT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Benefitfocus, Inc. offers cloud-based software solutions to consumers, employers, insurance carriers and brokers. The Company’s platform of products and services enable customers to efficiently shop, enroll, manage and exchange benefits information. Benefitfocus, Inc. is based in Charleston, South Carolina. “

Concord Medical Services Holdings Limited (NYSE:CCM) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Concord Medical Services Holdings Limited operates a large network of radiotherapy and diagnostic imaging centers in China. Most of the centers in their network are established through long-term lease and management services arrangements entered into with their hospital partners. Under these arrangements, Concord Medical receives a contracted percentage of each center’s revenue net of specified operating expenses. Each center is located on the premises of their hospital partners and is typically equipped with a primary unit of advanced radiotherapy or diagnostic imaging equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, PET-CT scanner or MRI scanner. “

Charter Communications (NASDAQ:CHTR) was upgraded by analysts at Telsey Advisory Group from a market perform rating to an outperform rating. Telsey Advisory Group currently has $450.00 price target on the stock, up from their previous price target of $340.00.

DHT Holdings (NYSE:DHT) had its buy rating reissued by analysts at Maxim Group. Maxim Group currently has a $7.00 price target on the stock.

US Ecology (NASDAQ:ECOL) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $60.00 price target on the stock.

Callaway Golf (NYSE:ELY) had its outperform rating reiterated by analysts at Imperial Capital. They currently have a $16.00 price target on the stock, up from their previous price target of $14.50.

Ichor Holdings (NASDAQ:ICHR) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $27.00 price target on the stock, up from their previous price target of $26.00.

Infinera Corporation (NASDAQ:INFN) had its strong-buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $13.00 price target on the stock, down from their previous price target of $14.50.

Intra-Cellular Therapies (NASDAQ:ITCI) had its buy rating reiterated by analysts at Cantor Fitzgerald. The analysts wrote, “Investors may be waiting for Godot (the FDA). We spoke with ITCI management this morning in conjunction with the release of 2Q17 results (no call was held). They noted that the company has responded to FDA questions regarding the non-clinical toxicology findings. Perhaps off-putting to investors, but consistent with the manner in which the FDA handles such issues, ITCI is challenged in providing any time-line along which the situation could be resolved.””

Lumentum Holdings (NASDAQ:LITE) had its buy rating reissued by analysts at Craig Hallum. They currently have a $75.00 target price on the stock.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reissued by analysts at Mizuho. They currently have a $70.00 target price on the stock, down from their previous target price of $73.00.

Neonode (NASDAQ:NEON) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating.

Neos Therapeutics (NASDAQ:NEOS) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $20.00 price target on the stock. The analysts wrote, “Positives from the quarter: 1) FDA approval of Cotempla XR-ODT in June of this year, with commercial availability in Fall of 2017, 2) On June 27, 2017, Neos announced the pricing of an underwritten public offering of $32.4MM value of common stock at a price of $6.75 per share, before deducting underwriting discounts and commissions and other offering expenses payable by Neos.””

NASDAQ Other Finance (NASDAQ:OTHER) had its buy rating reissued by analysts at Cowen and Company. The firm currently has a $7.50 target price on the stock.

Plains All American Pipeline, L.P. (NYSE:PAA) had its buy rating reissued by analysts at Barclays PLC. Barclays PLC currently has a $28.00 price target on the stock.

Stericycle (NASDAQ:SRCL) had its overweight rating reiterated by analysts at Barclays PLC. The firm currently has a $100.00 price target on the stock.

TripAdvisor (NASDAQ:TRIP) had its underperform rating reaffirmed by analysts at Bank of America Corporation. The firm currently has a $30.00 price target on the stock, down from their previous price target of $35.00.

TripAdvisor (NASDAQ:TRIP) had its hold rating reaffirmed by analysts at Barclays PLC.

Trivago N.V. ADS (NASDAQ:TRVG) had its overweight rating reaffirmed by analysts at J P Morgan Chase & Co. J P Morgan Chase & Co currently has a $23.00 target price on the stock.

Wendy’s Company (The) (NASDAQ:WEN) had its hold rating reiterated by analysts at Wedbush.

Receive News & Stock Ratings for AAC Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC Holdings Inc and related stocks with our FREE daily email newsletter.